Physician profile
Benjamin Lee
NPI 1871784967
$8,716.63
in general payments reported to CMS, 2019-2025
17 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $148 · 2021: $3,960 · 2022: $1,383 · 2023: $822 · 2024: $1,628 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493 · Travel and Lodging: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.50 |
| Travel and Lodging | $1,282.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,071.00 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $2,868.26 | 2021-2025 | Ellipsys Vascular Access System, Intellis Adaptivestim, Venaseal |
| Bard Peripheral Vascular, INC. | $494.79 | 2019-2025 | Venclose Maven Catheter, Venovo, Covera |
| Abbott Laboratories | $333.25 | 2023-2024 | Octrode, Proclaim |
| W. L. Gore & Associates, INC. | $223.79 | 2019-2025 | Gore Viabahn Endoprosthesis |
| Horizon Therapeutics Plc | $136.08 | 2021 | |
| Kerecis Limited | $132.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Cardiovascular Systems INC. | $128.45 | 2019-2021 | |
| Biotronik INC. | $103.83 | 2022-2023 | Passeo-18, Pulsar-18 T3 |
| Cook Medical LLC | $57.44 | 2019-2022 | |
| Covidien Lp | $37.62 | 2020 | |
| Medtronic Vascular, INC. | $27.52 | 2019 | |
| Fresenius USA Marketing, INC. | $24.90 | 2023 | Velphoro |
| Amgen INC. | $22.91 | 2024 | Krystexxa |
| Cormedix INC. | $19.99 | 2025 | Defencath |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.22 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.